Jeff Yass’s Neuphoria Therapeutics NEUP Stock Holding History
Bought
Maintained
Sold
Other funds holding NEUP
LCM
Jeff Yass's NEUP Position: Q3 2026 in Review
Jeff Yass opened a new position in Neuphoria Therapeutics (NEUP) in Q3 2026: 14,732 shares worth $52.4K. The stake represents ﹤0.01% of the portfolio and ranks #12869 among its holdings. This is a return to the name: Jeff Yass previously reported a position in NEUP as recently as Q3 2024.
Jeff Yass first reported a position in NEUP in Q3 2024 and has held it in 2 quarters since. 19 funds tracked by Wall St. Rank hold NEUP as of Q3 2026.
- Jeff Yass held 14,732 shares of Neuphoria Therapeutics worth $52.4K as of Q3 2026.
- Neuphoria Therapeutics was a new Jeff Yass position in Q3 2026.
- Neuphoria Therapeutics made up ﹤0.01% of Jeff Yass's portfolio in Q3 2026, its #12869 holding.
- Jeff Yass first reported a position in Neuphoria Therapeutics in Q3 2024 and has held it in 2 quarters since.
- 19 funds tracked by Wall St. Rank held Neuphoria Therapeutics as of Q3 2026.
Based on Susquehanna International Group's 13F filing for Q3 2026, filed 16 Nov 2026.